| Dr William Thomas Moy, PHARMD | |
|
300 Pasteur Dr, H0301, M/c 5616, Stanford, CA 94305-2200 | |
| (650) 725-5205 | |
| Not Available |
| Full Name | Dr William Thomas Moy |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 300 Pasteur Dr, Stanford, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164824116 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 58749 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr William Thomas Moy, PHARMD 300 Pasteur Dr, H0301, M/c 5616, Stanford, CA 94305-2200 Ph: (650) 725-5205 | Dr William Thomas Moy, PHARMD 300 Pasteur Dr, H0301, M/c 5616, Stanford, CA 94305-2200 Ph: (650) 725-5205 |
News Archive
Asahi Kasei Corporation, and ZOLL Medical Corporation today jointly announced that Asahi Kasei, Japan's leading diversified chemical manufacturer with businesses in the health care, chemicals & fibers, homes & construction materials, and electronics sectors, has entered into a definitive merger agreement with ZOLL, a manufacturer of resuscitation and critical care devices and related software solutions, pursuant to which Asahi Kasei will acquire ZOLL for approximately $2.21 billion.
In a recent issue of The Journal of Chemical Physics , published by the American Institute of Physics (AIP), a group of researchers at the University of California, Berkeley and Los Alamos National Laboratory describe the first comprehensive, molecular-level numerical study of gene therapy.
In a new study, researchers from Hiroshima University have identified a new form of depression that could be used to inform a new generation of treatments.
A test using cultured cells provides an effective way to screen drugs against Huntington's disease and shows that two compounds - memantine and riluzole - are most effective at keeping cells alive under conditions that mimic the disorder, UT Southwestern Medical Center researchers report.
Copper deficiency diseases can be devastating. Symptoms can range from crippling neurological degeneration in Menkes disease ,a classic copper deficiency disease to brittle bones, anaemia and defective skin pigmentation in gastric bypass patients. Unfortunately, very little is known about how the body uses this essential nutrient. Knowing that melanocytes (the cells that give rise to hair, skin and eye pigmentation) are dramatically affected by the effects of copper deficiency, Elizabeth Patton from the University of Edinburgh, UK, and other colleagues from UK and US based labs decided to find out how melanocytes metabolise copper.
› Verified 6 days ago
Kathi Salmon Lucas, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 Pasteur Dr # H0301, Stanford, CA 94305 Phone: 650-725-5804 | |
Sandy On, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 Pasteur Dr, Rm H0301, M/c 5616, Stanford, CA 94305 Phone: 650-498-4387 | |
Dr. Christopher Jordan Diaz, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-724-3449 | |
Ms. Ann Vongspanich, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-736-2789 | |
Noah Chung Fang, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-8363 | |
Dr. Michael Gregory Blyumin, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 Pasteur Dr Rm H0301c, Stanford, CA 94305 Phone: 650-493-9973 |